Association between human paraoxonase 1 activity and intima-media thickness in subjects under 55 years of age with carotid artery disease

Cerebrovascular Diseases

Volumn 25, Issue 1-2, 2008, Pages 122-128

  Harangi, Mariann ^a   Seres, Ildiko ^a   Magyar, Maria T ^a   Csipo, Istvan ^a   Sipka, Sandor ^a   Valikovics, Attila ^b   Csiba, Laszlo ^a   Bereczki, Daniel ^a   Paragh, Gyorgy ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b Borsod County Teaching Hospital   (Hungary)

Author keywords

Anti oxidized low density lipoprotein antibody; Carotid artery disease; Intima media thickness; Paraoxonase

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY;

ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; ULTRASOUND;

AGE FACTORS; ARYLDIALKYLPHOSPHATASE; CAROTID ARTERY DISEASES; CAROTID ARTERY, COMMON; CASE-CONTROL STUDIES; CHOLESTEROL; FEMALE; HUMANS; MALE; MIDDLE AGED; TUNICA INTIMA; TUNICA MEDIA;

EID: 39549118353     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000112322     Document Type: Article

References (35)

1. Flegar-Mestric Z, Vrhovski-Hebrang D, Preden-Kerekovic V, Perkov S, Hebrang A, Grga A, Janus D, Vidjak V: C-reactive protein level in severe stenosis of cerebral arteries. Cerebrovasc Dis 2007;23:430-434.
2. Itabe H: Oxidized low-density lipoproteins: what is understood and what remains to be clarified. Biol Pharm Bull 2003;26:1-9.
3. Witzum JL: Immunological response to oxidized LDL. Atherosclerosis 1997;131(suppl):S9-S11.
4. Salonen JT, Yla-Herttuala S, Yamamoto R, Butler S, Korpeala H, Salonen R, Nyyssonen K, Palinski W, Witzum JL: Autoantibody against oxidized LDL and progression of carotid artherosclerosis. Lancet 1992;339:883-887.
5. Shoji T, Nishizawa Y, Fukumoto M, Shimamura K, Kimura J, Kanda H, Emoto M, Kawagishi T, Morii H: Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects. Atherosclerosis 2000;48:171-177.
6. Mackness MI, Arrol S, Abbott CA, Durrington PN: Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis 1993;104:129-135.
7. Mackness B, Mackness MI, Arrol S, Turkie W, Durrington PN: Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon. Br J Pharmacol 1997;122:265-268.
8. Leviev I, James RW: Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations. Arterioscler Thromb Vasc Biol 2000;20:516-521.
9. La Du BN, Eckerson HW: The polymorphic paraoxonase/arylesterase isozymes of human serum. Fed Proc 1984;43:2338-2341.
10. Markus H, Kaposzta Z, Ditrich R, Wolfe C, Ali N, Powel J, Mendell M, Cullinane M: Increased common carotid intima-media thickness in UK African Caribbeans and its relation to chronic inflammation and vascular candidate gene polymorphisms. Stroke 2001;32:2465-2471.
11. Fortunato G, Rubba P, Panico S, Trono D, Tinto N, Mazzaccara C, De Michele M, Ianuzzi A, Vitale DF, Salvatore F, Sacchetti L: A paraoxonase gene polymorphism, PON 1 (55), as an independent risk factor for increased carotid intima-media thickness in middle-aged women. Atherosclerosis 2003;167:141-148.
12. Roest M, Jansen AC, Barendrecht A, Leus FR, Kastelein JJ, Voorbij HA: Variation at the paraoxonase gene locus contributes to carotid arterial wall thickness in subjects with familial hypercholesterolemia. Clin Biochem 2005;38:123-127.
13. Karvonen J, Kauma H, Paivansalo M, Kesaniemi YA: Paraoxonase-1 gene Leu-Met55 and Gln-Arg192 polymorphisms are not associated with carotid artery atherosclerosis in a population-based cohort. Eur J Cardiovasc Prev Rehabil 2004;11:511-512.
14. Srinivasan SR, Li S, Chen W, Tang R, Bond MG, Boerwinkle E, Berenson GS: Q192R polymorphism of the paraoxonase 1 gene and its association with serum lipoprotein variables and carotid artery intima-media thickness in young adults from biracial community. The Bogalusa Heart Study. Atherosclerosis 2004;177:167-174.
15. Van Himbergen T, Roest M, De Waart F, De Graaf J, Voorbij H, Van Tits L, Stalenhoef A: Paraoxonase genotype, LDL-oxidation and carotid atherosclerosis in male life-long smokers. Free Radic Res 2004;38:553-560.
16. Leus FR, Wittekoek ME, Prins J, Kastelein JJ, Voorbij HA: Paraoxonase gene polymorphisms are associated with carotid arterial wall thickness in subjects with familial hypercholesterolemia. Atherosclerosis 2000;149:371-377.
17. Malin R, Loimaala A, Nenonen A, Mercuri M, Vuori I, Pasanen M, Oja P, Bond G, Koivula T, Lehtimaki T: Relationship between high-density lipoprotein paraoxonase gene M/L55 polymorphism and carotid atherosclerosis differs in smoking and non-smoking men. Metabolism 2001;50:1095-1101.
18. Slowik A, Wloch D, Szermer P, Wolkow P, Malecki M, Pera J, Turaj W, Dziedzic T, Klimkowicz-Mrowiec A, Kopec G, Figlewicz DA, Szczudlik A: Paraoxonase 2 gene C311S polymorphism is associated with a risk of large vessel disease stroke in a Polish population. Cerebrovasc Dis 2007;23:395-400.
19. Zuliani G, Cherubini A, Volpato S, Palmieri E, Mecocci P, De Rango P, Cao P, Costantini F, Mezzetti A, Mascoli F, Senin U, Fellin R: Genetic factors associated with the absence of atherosclerosis in octogenarians. J Gerontol A Biol Sci Med Sci 2002;57:M611-M615.
20. Jarvik GP, Rozek LS, Brophy VH, Hatsukami TS, Richter RJ, Schellenberg GD, Furlong CE: Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1-192 or PON1-55 genotype. Arterioscler Thromb Vasc Biol 2000;20:2441-2447.
21. Balla J, Magyar MT, Bereczki D, Valikovics A, Nagy E, Barna E, Pal A, Balla G, Csiba L, Blasko G: Serum levels of platelet released CD40 ligand are increased in early onset occlusive carotid artery disease. Dis Markers 2006;22:133-140.
22. European Carotid Surgery Trialists' Collaborative Group: MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet 1991;337:1235-1243.
23. Magyar MT, Szikszai Z, Balla J, Valikovics A, Kappelmayer J, Imre S, Balla G, Jeney V, Csiba L, Bereczki D: Early-onset carotid atherosclerosis is associated with increased intima media thickness and elevated serum levels of inflammatory markers. Stroke 2003;34:58-63.
24. Howard G, Sharrett AR, Heiss G, Evans GW, Chambless LE, Riley WA, Burke GL: Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators. Stroke 1993;24:1297-1304.
25. Bots ML: Carotid intima-media thickness as a surrogate marker for cardiovascular disease in intervention studies. Curr Med Res Opin 2006;22:2181-2190.
26. Kitagawa K, Hougaku H, Yamagami H, Hashimoto H, Itoh T, Shimizu Y, Takahashi D, Murata S, Seike Y, Kondo K, Hoshi T, Furukado S, Abe Y, Yagita Y, Sakaguchi M, Tagaya M, Etani H, Fukunaga R, Nagai Y, Matsumoto M, Hori M: Carotid intima-media thickness and risk of cardiovascular events in high-risk patients: results of the Osaka Follow-Up Study for Carotid Atherosclerosis 2 (OSACA2 Study). Cerebrovasc Dis 2007;24:35-42.
27. Magyar MT, Bereczki D: Cholesterol and the cerebral circulation. Future Lipidol 2007;2:211-228.
28. Hansson GK, Libby P, Schonbeck U, Yan ZQ: Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 2002;91:281-291.
29. Gnasso A, Motti C, Irace C, Di Gennaro I, Pujia A, Leto E, Ciamei M, Crivaro A, Bernardini S, Federici G, Cortese C: The Arg allele in position 192 of PON1 is associated with carotid atherosclerosis in subjects with elevated HDLs. Atherosclerosis 2002;164:289-295.
30. Dessi M, Gnasso A, Motti C, Pujia A, Irace C, Casciani S, Staffa F, Federici G, Cortese C: Influence of the human paraoxonase polymorphism (PON1 192) on the carotid-wall thickening in a healthy population. Coron Artery Dis 1999;10:595-599.
31. Campo S, Sardo MA, Trimarchi G, Bonaiuto M, Castaldo M, Fontana L, Bonaiuto A, Bitto A, Saitta C, Daitta A: The paraoxonase promoter polymorphism (-107) T→C is not associated with carotid intima-media thickness in Sicilian hypercholesterolemic patients. Clin Biochem 2004;37:388-394.
32. Mackness B, Mackness MI: Paraoxonase 1 and atherosclerosis: is the gene or the protein more important? Free Radic Biol Med 2004;37:1317-1323.
33. Rozek LS, Hatsukami TS, Richter RJ, Ranchalis J, Nakayama K, McKinstry LA, Gortner DA, Boyko E, Schelleberg GD, Furlong CE, Jarvik GP: The correlation of paraoxonase (PON1) activity with lipid and lipoprotein levels differs with cardiovascular disease status. J Lipid Res 2005;46:1888-1895.
34. Kiortsis DN, Tsouli S, Lourdia ES, Xydis V, Argyropoulou MT, Elisaf M, Tselepis AD: Lack of association between carotid intimamedia thickness and PAF-acetylhydrolase mass and activity in patients with primary hyperlipidemia. Angiology 2005;56:451-458.
35. Roest M, Rodenburg J, Wiegman A, Kastelein JJ, Voorbij HA: Paraoxonase genotype and carotid intima-media thickness in children with familial hypercholesterolemia. Eur J Cardiovasc Prev Rehabil 2006;13:464-466.